Oyster Point Pharmaceuticals
A clinical stage pharmaceutical company focused on the discovery development & commercialization .
Launch date
Employees
Market cap
$300m
Enterprise valuation
$326m (Public information from Jan 2023)
Share price
$11.17 OYST
San Francisco California (HQ)
Authorizing premium user...